These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33401979)

  • 1. Using in silico modelling and FRET-based assays in the discovery of novel FDA-approved drugs as inhibitors of MERS-CoV helicase.
    Mehyar N; Mashhour A; Islam I; Gul S; Adedeji AO; Askar AS; Boudjelal M
    SAR QSAR Environ Res; 2021 Jan; 32(1):51-70. PubMed ID: 33401979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Zafirlukast as a novel SARS-CoV-2 helicase inhibitor using in silico modelling and a FRET-based assay.
    Mehyar N; Mashhour A; Islam I; Alhadrami HA; Tolah AM; Alghanem B; Alkhaldi S; Somaie BA; Al Ghobain M; Alobaida Y; Alaskar AS; Boudjelal M
    SAR QSAR Environ Res; 2021 Dec; 32(12):963-983. PubMed ID: 34818959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and molecular docking of novel triazole derivatives as potential CoV helicase inhibitors.
    Zaher NH; Mostafa MI; Altaher AY
    Acta Pharm; 2020 Jun; 70(2):145-159. PubMed ID: 31955138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Gurung AB
    Gene Rep; 2020 Dec; 21():100860. PubMed ID: 32875166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
    Martinez MA
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Computational modeling of the bat HKU4 coronavirus 3CL
    Abuhammad A; Al-Aqtash RA; Anson BJ; Mesecar AD; Taha MO
    J Mol Recognit; 2017 Nov; 30(11):. PubMed ID: 28608547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.
    Scroggs SLP; Offerdahl DK; Flather DP; Morris CN; Kendall BL; Broeckel RM; Beare PA; Bloom ME
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33374514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elucidating the Drug Repurposing Spectra of COVID-19 with its Analogues SARS and MERS.
    Mishra J; Prasun C; Sahoo PK; Nair MS
    Mini Rev Med Chem; 2021; 21(20):3191-3202. PubMed ID: 33632095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current approaches for target-specific drug discovery using natural compounds against SARS-CoV-2 infection.
    Khare P; Sahu U; Pandey SC; Samant M
    Virus Res; 2020 Dec; 290():198169. PubMed ID: 32979476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SARS-CoV-2 helicase as a target for antiviral therapy: Identification of potential small molecule inhibitors by in silico modelling.
    Pitsillou E; Liang J; Hung A; Karagiannis TC
    J Mol Graph Model; 2022 Jul; 114():108193. PubMed ID: 35462185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A global treatments for coronaviruses including COVID-19.
    Yousefi B; Valizadeh S; Ghaffari H; Vahedi A; Karbalaei M; Eslami M
    J Cell Physiol; 2020 Dec; 235(12):9133-9142. PubMed ID: 32394467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
    de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL
    Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH
    Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.
    Li C; Chu H; Liu X; Chiu MC; Zhao X; Wang D; Wei Y; Hou Y; Shuai H; Cai J; Chan JF; Zhou J; Yuen KY
    Emerg Microbes Infect; 2020 Dec; 9(1):2663-2672. PubMed ID: 33179566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Small-Molecule MERS-CoV Inhibitors.
    Liang R; Wang L; Zhang N; Deng X; Su M; Su Y; Hu L; He C; Ying T; Jiang S; Yu F
    Viruses; 2018 Dec; 10(12):. PubMed ID: 30562987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.
    Ko M; Chang SY; Byun SY; Ianevski A; Choi I; Pham Hung d'Alexandry d'Orengiani AL; Ravlo E; Wang W; Bjørås M; Kainov DE; Shum D; Min JY; Windisch MP
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.